How to Judge If a Company Is Over-Packaging Its Growth Story in the Prospectus

Hong Kong’s IPO market in 2025 has witnessed a sharpened regulatory focus on the veracity of forward-looking statements, directly challenging the long-standing practice of “storytelling” in prospectuses. The SFC’s September 2024 consultation conclusions on the Listing Regime, which took full effect in Q1 2025, explicitly enhanced requirements for profit forecasts and projections under the Code on Takeovers and Mergers and the Listing Rules, mandating that any financial projection in a listing document must be supported by a clear, verifiable basis and a sensitivity analysis (SFC, Consultation Conclusions on the Listing Regime, September 2024). Simultaneously, HKEX’s updated guidance letter HKEX-GL119-24, issued in December 2024, tightened the disclosure standards for “market opportunity” sections in prospectuses, requiring sponsors to demonstrate that total addressable market (TAM) figures are sourced from independent, third-party research with a clear methodology, rather than from management’s internal estimates. This twin regulatory push means that the era of a company dressing a stagnant business in a growth narrative—citing a billion-dollar TAM or projecting 50% CAGR without a demonstrable path—is effectively over. For IBD analysts and IPO project teams, the core question is no longer whether a story is compelling, but whether it is defensible. This article provides a systematic framework to dissect a prospectus’s growth story, using specific regulatory references and quantitative tests to separate substantiated claims from over-packaged narratives.

The Three Red Flags in Market Sizing and TAM Claims

The most common over-packaging technique in Hong Kong prospectuses is the inflation of the Total Addressable Market (TAM). A company operating in a niche sub-sector of, say, the PRC enterprise software market might cite a TAM of HKD 50 billion, derived from a global consultancy report, while its actual revenue is HKD 100 million. The HKEX guidance letter HKEX-GL119-24 explicitly requires that any TAM figure used in a prospectus must be “specific to the issuer’s actual or intended business scope” and must not include market segments the issuer has no realistic plan to enter.

The TAM-to-Revenue Ratio Test

The first quantitative test is the TAM-to-Revenue ratio. If a company’s cited TAM exceeds its latest annual revenue by more than 500x, the claim warrants immediate scrutiny. For example, a biotech firm with no approved product and HKD 10 million in licensing revenue citing a TAM of HKD 100 billion for a specific therapeutic area is statistically improbable unless it has a clear, patented first-mover advantage. The prospectus must disclose the methodology behind the TAM calculation—whether it is a top-down estimate from industry reports (e.g., Frost & Sullivan, IDC) or a bottom-up calculation based on addressable customer counts. A top-down estimate without a bottom-up validation is a red flag. Under HKEX Listing Rule 11.07, any profit forecast or projection, which implicitly includes market share assumptions derived from TAM, must be reported on by the sponsor and the reporting accountant. If the TAM figure is not directly tied to a revenue projection, the sponsor must still justify its inclusion as a material disclosure.

The Growth Rate vs. Industry Benchmark Mismatch

A second red flag is a projected growth rate that significantly exceeds the industry average without a credible explanation. The prospectus should cite independent industry growth rates—for instance, from the HKTDC, the PRC National Bureau of Statistics, or a named industry association. If a company projects a 40% CAGR for its core business over the next three years, while the independent source for its industry projects 8-12% CAGR, the burden of proof shifts to the issuer. The prospectus must detail the specific drivers—new product launches, market expansion into specific provinces, or contract wins with named clients. Vague references to “industry tailwinds” or “digital transformation” are insufficient. The SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC (Chapter 17) requires sponsors to have a reasonable basis for all material statements in a listing document. A growth rate that is 3x the industry average without a contractually secured order book or a signed distribution agreement is a clear indicator of over-packaging.

The “Market Opportunity” Slide as a Distraction

Many prospectuses, particularly for Main Board listings, dedicate a full section to “Market Opportunity” that is visually impressive but analytically hollow. This section often includes a chart showing a steep upward trajectory for the industry, with the issuer’s logo placed at the bottom left, implying it will capture a disproportionate share of that growth. The critical test is whether the prospectus provides a market share analysis that is consistent with the TAM. If the issuer claims a 0.5% market share in a HKD 50 billion market, but its revenue is HKD 100 million (implying a 0.2% share), the discrepancy must be explained. A reasonable explanation might be that the TAM includes a broader definition that the issuer does not fully serve. However, if no explanation is provided, the market opportunity section is effectively a marketing slide, not a disclosure. Under HKEX Listing Rule 2.03, the listing document must contain “full, accurate and timely disclosure of information.” A market opportunity slide that is materially misleading by omission is a breach.

The Sponsor’s Role in Validating the Growth Engine

The sponsor is the gatekeeper for the growth story. Under the SFC’s Sponsor Regulation, the sponsor must conduct reasonable due diligence on all forward-looking statements. The 2025 regulatory update has made this responsibility more explicit, requiring sponsors to document the basis for every key assumption.

The “Show Me the Contract” Test

The most reliable indicator of a genuine growth story is the presence of a clear, contractually secured revenue pipeline. The prospectus should disclose the backlog of signed contracts or purchase orders, ideally with a weighted-average duration. For example, a SaaS company with an Annual Recurring Revenue (ARR) of HKD 200 million and a net dollar retention rate of 120% has a demonstrable growth engine. In contrast, a company that cites a pipeline of “letters of intent” or “memoranda of understanding” (MOUs) without binding commitments is presenting a story, not a fact. Under HKEX Listing Rule 11.10, any reference to a contract or agreement that is material to the issuer’s business must be disclosed in full. If the prospectus mentions a “strategic partnership” with a Fortune 500 company but does not disclose the revenue-sharing terms or the duration of the agreement, the growth story is likely over-packaged. The sponsor must verify these contracts directly, not rely on management representations.

The Gross Margin Stability as a Growth Indicator

A company projecting high revenue growth must also demonstrate that its gross margin is sustainable or improving. A growth story that relies on price cuts to gain market share is inherently fragile. The prospectus should show a five-year historical gross margin trend. If revenue is growing at 30% YoY but gross margin is declining from 45% to 35%, the growth is likely coming at the expense of profitability. This is a classic sign of a “growth at all costs” strategy that may not be sustainable. Under HKEX Listing Rule 11.07, the profit forecast must be consistent with the historical financial statements. A declining gross margin with a rising revenue forecast is a red flag that the growth story is being over-packaged to mask deteriorating unit economics.

The Cash Flow Reality Check

Revenue growth that is not accompanied by positive operating cash flow is a significant warning sign. The prospectus should include a statement of cash flows for the track record period. If the issuer’s operating cash flow is consistently negative while revenue is growing, the company is consuming cash to generate sales—potentially through aggressive credit terms to customers or high sales and marketing spend. The sponsor must assess whether the company has sufficient working capital to fund this growth until it reaches profitability. Under HKEX Listing Rule 11.12A, a listing document must include a statement of working capital sufficiency for at least 12 months from the date of the prospectus. A growth story that relies on continuous external funding is not a growth story; it is a capital-intensive business model. The prospectus must disclose the cash burn rate and the expected timeline to cash flow breakeven. If these are absent, the narrative is incomplete.

Cross-Border Structure as a Growth Story Amplifier

For many PRC-incorporated companies listing in Hong Kong, the corporate structure itself—often a Cayman Islands holding company with a VIE or contractual arrangement—can be used to amplify the growth narrative. The prospectus must clearly disclose the risks associated with the structure, but the structure can also be used to inflate the apparent scale of the business.

The VIE Structure and Revenue Aggregation

A VIE structure allows a Hong Kong-listed entity to consolidate the financial results of a PRC operating company. This can create an illusion of growth if the operating company is a small entity that is being aggregated with other entities. The prospectus must disclose the financials of each material subsidiary, not just the consolidated group. If the growth story is driven by one subsidiary while others are stagnant or loss-making, this must be highlighted. The SFC’s Guidance Note on the Disclosure of VIE Structures (2018) requires issuers to clearly explain the flow of economic benefits. If the growth story is disproportionately dependent on a single VIE entity, the risk of regulatory intervention in the PRC (e.g., the 2021 data security laws) must be clearly disclosed. A growth story that does not address this structural risk is over-packaged.

The Tax Holiday as a Growth Driver

Many PRC companies benefit from a “High and New Technology Enterprise” (HNTE) tax holiday, reducing their corporate income tax rate from 25% to 15%. This can significantly inflate net profit figures. The prospectus must disclose the expiry date of this tax holiday. If the company’s growth story is built on a net profit margin that is artificially boosted by a tax holiday expiring in two years, the underlying business is less profitable than it appears. Under HKEX Listing Rule 11.07, the profit forecast must be adjusted for non-recurring items. A tax holiday is a non-recurring benefit, and the prospectus should present a “normalized” effective tax rate. If the prospectus only shows the post-tax-holiday profit, the growth story is being over-packaged.

The Currency and Jurisdiction Risk

A growth story that relies on revenue from a single jurisdiction (e.g., the PRC) must be weighed against currency and geopolitical risk. The prospectus should disclose the impact of RMB depreciation on reported HKD or USD earnings. If the company projects 20% revenue growth in RMB terms but the prospectus uses a constant exchange rate that is materially different from the spot rate, the HKD-denominated growth figure is misleading. Under HKEX Listing Rule 11.10, any material assumption must be clearly stated. A growth story that ignores currency risk is incomplete.

The Management Discussion and Analysis (MD&A) as a Litmus Test

The MD&A section of the prospectus is where the growth story is most vulnerable. It must reconcile the narrative with the financials. A well-written MD&A will explain why revenue grew in a specific year—was it volume growth, price increases, or a change in product mix? An over-packaged MD&A will use vague language like “due to increased market demand” or “successful execution of our strategy.”

The Revenue Decomposition Test

The first test is to decompose revenue growth into its components: volume, price, and mix. The prospectus should provide a table showing the breakdown. If revenue grew 20% but volume grew 5% and price grew 15%, the growth is driven by pricing power, which is sustainable. If volume grew 20% but price declined 5%, the growth is volume-driven and may be unsustainable if the market is saturated. If no decomposition is provided, the growth story is not fully disclosed. The SFC’s Code of Conduct requires sponsors to ensure that the MD&A is “balanced and consistent with the financial statements.” A lack of decomposition is a red flag.

The Segment-Level Analysis

If the issuer operates in multiple segments, the prospectus must provide segment-level financial data under HKFRS 8. A common over-packaging technique is to highlight the fastest-growing segment while downplaying the stagnant or declining core business. The prospectus should show revenue, profit, and assets for each segment. If the “growth story” is entirely dependent on a new segment that contributes less than 10% of total revenue, the narrative is misleading. The sponsor must ensure that the headline growth rate is not driven by a small, unprofitable segment.

The Seasonality and One-Offs

Finally, the prospectus must address seasonality and one-off items. A company that reports a 50% revenue increase in the latest half-year may simply be benefiting from a large, one-off contract. The prospectus should disclose whether the revenue is recurring or transactional. Under HKEX Listing Rule 11.07, any profit forecast must exclude non-recurring items. If the growth story is built on a one-off event, it is not a sustainable growth story.

Actionable Takeaways for IPO Project Teams

1. Apply the TAM-to-Revenue ratio test: If the ratio exceeds 500x, demand a bottom-up validation from the issuer and a written explanation from the sponsor, referencing HKEX-GL119-24.
2. Verify the growth rate against independent industry benchmarks: If the issuer’s projected CAGR is more than 2x the independent industry rate, require a written basis from the sponsor, citing the SFC’s Code of Conduct Chapter 17.
3. Demand a contract backlog disclosure: If the prospectus mentions a pipeline without binding contracts, flag it as a material omission under HKEX Listing Rule 11.10.
4. Normalize for tax holidays and non-recurring items: Present a “normalized” net profit figure that excludes the HNTE tax holiday benefit, and ensure the sponsor confirms this is disclosed under Listing Rule 11.07.
5. Insist on a revenue decomposition table in the MD&A: If the prospectus does not break down revenue growth into volume, price, and mix, request a revised draft from the sponsor, as this is a red flag under the SFC’s Code of Conduct.